ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

No reported Gross Profit figures are available to summarize.

Gross Profit history

Currency unavailable · from the income statement

No Gross Profit data reported for this period type.

Gross Profit vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Gross Profit for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MGTXMeiraGTx Holdings plcLTM Mar 2026$73.09M USD+682.6%+68.8%91.6%
WVEWave Life Sciences Ltd.LTM Mar 2026$67.34M USD-34.5%+110.2%93.8%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$41.35M USD-69.4%-32.2%91.2%
STOKStoke Therapeutics, Inc.LTM Mar 2026$28.99M USD-84.7%+145.9%90.4%
RNAAtrium Therapeutics, Inc.FY2025$18.62M USD——100.0%
PRQRProQR Therapeutics N.V.LTM Mar 2026€12.06M EUR-36.4%+52.2%89.7%
SLNSilence Therapeutics plcLTM Mar 2026$612.12K USD—-62.8%66.4%
BNTCBenitec Biopharma Inc.LTM Mar 2026-$475K USD-28.7%——
PRMEPrime Medicine, Inc.LTM Mar 2026-$43.68M USD-1235.6%—1082.7%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-36.4%+60.5%91.4%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.